Sinil Pharmaceutical Co., Ltd. (KOSDAQ:012790)
South Korea · Delayed Price · Currency is KRW 6,480.00
+40.00 (0.62%)
At close: Oct 2, 2026
Sinil Pharmaceutical Market Cap
Sinil Pharmaceutical has a market cap or net worth of 73.72 billion as of October 2, 2026. Its market cap has increased by 5.54% in one year.
Market Cap
73.72B
Enterprise Value
33.02B
Revenue
86.82B
Ranking
n/a
PE Ratio
11.67
Stock Price
6,480.00
ChartMarket Cap Chart
Since November 20, 2000, Sinil Pharmaceutical's market cap has increased from 16.83B to 73.72B, an increase of 338.09%. That is a compound annual growth rate of 5.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 73.72B | 6.75% |
| Dec 30, 2025 | 69.05B | -5.60% |
| Dec 30, 2024 | 73.15B | -16.60% |
| Dec 28, 2023 | 87.71B | -9.43% |
| Dec 29, 2022 | 96.84B | -24.53% |
| Dec 30, 2021 | 128.31B | -48.11% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| DongKoo Bio & Pharma | 95.05B |
| H.PIO | 87.34B |
| Samik Pharmaceutical Company LTD. | 86.08B |
| Sam-A Pharm. | 84.53B |
| Daehan Nupharm | 78.46B |
| Pharos iBio | 77.93B |
| Polaris AI Pharma | 72.66B |
| Sinsin Pharmaceutical | 67.58B |